E-Z-EM ponders IPO for AngioDynamics subsidiary
This article was originally published in Clinica
Executive Summary
Gastrointestinal contrast media specialist E-Z-EM, of Lake Success, New York, is considering a spin-off or initial public offering of its wholly owned subsidiary, AngioDynamics. "The view is that the IPO market, which has been weak for a number of years, is turning, and that activity is expected from the beginning of 2004," E-Z-EM chief financial officer Dennis Curtin told Clinica Direct.